Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial
Author:
How Jeffrey A.ORCID, Dang Minghao, Lee Sanghoon, Fellman Bryan, Westin Shannon N., Sood Anil K., Fleming Nicole D., Shafer Aaron, Yuan Ying, Liu Jinsong, Zhao Li, Celestino Joseph, Hajek Richard, Morgan Margaret B., Parra Edwin R., Laberiano Fernandez Caddie D., Arrechedera Claudio A., Solis Soto Luisa Maren, Schmeler Kathleen M., Nick Alpa, Lu Karen H., Coleman Robert, Wang Linghua, Jazaeri Amir A.
|
|